[11 March 2013]
Products Affected - Description
Diphenhydramine injection, 50 mg/mL
Reason for the Shortage
- Hospira discontinued diphenhydramine iSecure syringes in 2011.
- Pfizer discontinued all Benadryl injection in 2005.
- IMS discontinued diphenhydramine injection in April 2008.
Available Products
Diphenhydramine injection, 50 mg/mL, APP
1 mL vial (NDC 63323-0664-01)
Diphenhydramine injection, 50 mg/mL, Hospira
1 mL Carpuject syringe (NDC 00409-2290-31)
Diphenhydramine injection, 50 mg/mL, Mylan Institutional
10 mL vial (NDC 67457-0124-10)
Diphenhydramine injection, 50 mg/mL, West-Ward (formerly Baxter products)
1 mL vial (NDC 00641-0376-25)
Estimated Resupply Dates
All presentations are currently available.
Related Shortages
Updated
March 11, 2013; March 1, 2013; January 23, 2013; December 21, 2012; December 12, 2012; December 5, 2012; November 7, 2012; October 22, 2012; October 4, 2012; August 14 and 29, 2012; July 26, 2012; June 21, 2012; May 18, 2012; April 24, 2012; March 29, 2012; March 21, 2012; February 24, 2012; February 9, 2012; January 24, 2012; January 13, 2012; December 14, 2011; November 16, 2011; November 16, 2011; November 2, 2011; October 26, 2011; October 18, 2011; October 13, 2011; October 5, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins